Address
42 Hayarkon Street
Yavne, HM 8122745
Israel
Phone
972 7 797 14100
Website
Sector
Healthcare
Industry
Biotechnology
Employees
121
First IPO Date
March 20, 2014
| Name | Title | Pay | Year Born |
| Ofer Gonen | Chief Executive Officer | 834,000 | 1973 |
| Yaron Meyer Adv. | Executive Vice President, General Counsel & Corporate Secretary | 337,000 | 1979 |
| Hani Luxenburg | Chief Financial Officer | 420,000 | 1974 |
| Shmulik Hess | Chief Operating Officer & Chief Commercial Officer | 426,000 | 1974 |
| Ety Klinger | Chief Medical Officer | 428,000 | 1962 |
| Liron Gal | Vice President of Manufacturing Science & Technology | 0 | N/A |
| Robert J. Snyder FFPM | Senior Vice President of Global Medical Affairs | 0 | 1951 |
| Hagit Mashiach | Vice President of Human Resources | 0 | N/A |
| Barry J. Wolfenson | Executive Vice President of Strategy & Corporate Development | 0 | 1967 |
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.